Michael Higgins, MD
Orthopaedic Surgery · Hampton, VANPI 1760460570
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $11,645 of the $14,153 with a category attached, or 82.3%. Kyocera Medical Technologies, Inc. accounts for 84.4% of it on its own, with 7 other manufacturers making up the rest. 2025 is the largest year on record at $10,255, more than ten times the $324 reported in 2019.
Across 45 payments — averaging $314.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Kyocera Medical Technologies, Inc.$12K
- Stryker$677
- Zimmer Biomet$664
- Medacta USA, Inc.$597
- Johnson & Johnson$92
- Ferring Pharmaceuticals Inc.$80
- plus $97 from 2 others
Across 47 payments — averaging $3977.45 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Zimmer Biomet$187K
What the payments were for
- Consulting fees$11,64582%
- Food & beverage$2,50818%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Kyocera Medical Technologies, Inc. | 4 | $11,946 |
| Stryker | 16 | $677 |
| Zimmer Biomet | 7 | $664 |
| Medacta USA, Inc. | 6 | $597 |
| Johnson & Johnson | 3 | $92 |
| Ferring Pharmaceuticals Inc. | 5 | $80 |
| Bioventus LLC | 3 | $77 |
| Smith+Nephew | 1 | $21 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Persona$413
- MAKO$266
- GMK SPHERE$258
- TRIATHLON$145
- AMISTEM$125
- ROSA-Knee$124
- Connected Health-None$107
How this compares
$14,153 in reported general payments places this provider in the 75th percentile of 473 orthopaedic surgery providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Cephalexin | 141 | $793 |
| Meloxicam | 174 | $507 |
| Methylprednisolone | 65 | $452 |
| Diclofenac Sodium | 17 | $275 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 16 | $95 |
| Amoxicillin | 23 | $30 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Hampton
- Dale YoungNorth Chesterfield$10.9M
- James DowdVirginia Beach$6.1M
- Mark de BloisNorth Chesterfield$4M
- Cato LaurencinCharlottesville$3.5M
- Randall PeytonSterling$2.9M
- William MihalkoCharlottesville$2M
- David MillerNorth Chesterfield$1.7M
- Keith LawhornFairfax$1.6M
- Joseph GonduskyVirginia Beach$1.2M
- Joshua HerzogNorth Chesterfield$1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.